Pharma saw huge reputation gains in the last year. It should make sure not to squander them, expert says

If it seems the pharmaceutical industry is in the press more these days amid the COVID-19 pandemic and the drug pricing battle in Washington, D.C., that's because it is. But while the industry has faced decades of negative sentiment among Americans, more people are coming around to see pharma's point of view, new Harris Poll data show.